EMRGX
Price
$6.76
Change
-$0.07 (-1.02%)
Updated
Sep 6 closing price
VEIEX
Price
$27.63
Change
-$0.39 (-1.39%)
Updated
Sep 6 closing price
Ad is loading...

EMRGX vs VEIEX

Header iconEMRGX vs VEIEX Comparison
Open Charts EMRGX vs VEIEXBanner chart's image
Emerging Markets Growth Fund M
Price$6.76
Change-$0.07 (-1.02%)
VolumeN/A
CapitalizationN/A
Vanguard Emerging Mkts Stock Idx I
Price$27.63
Change-$0.39 (-1.39%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
EMRGX vs VEIEX Comparison Chart
Loading...
VS
EMRGX vs. VEIEX commentary
Sep 08, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EMRGX is a Buy and VEIEX is a Buy.

FUNDAMENTALS
Fundamentals
VEIEX has more cash in the bank: 108B vs. EMRGX (1.28B). VEIEX pays higher dividends than EMRGX: VEIEX (3.27) vs EMRGX (1.47). EMRGX was incepted earlier than VEIEX: EMRGX (38 years) vs VEIEX (30 years). EMRGX is a more actively managed with annual turnover of: 38.00 vs. VEIEX (5.00). VEIEX has a lower initial minimum investment than EMRGX: VEIEX (0) vs EMRGX (1000000). VEIEX annual gain was more profitable for investors over the last year : 11.44 vs. EMRGX (5.89). VEIEX return over 5 years is better than : 16.99 vs. EMRGX (-9.81).
EMRGXVEIEXEMRGX / VEIEX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence38 years30 years-
Gain YTD3.1727.87740%
Front LoadN/AN/A-
Min. Initial Investment10000000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.28B108B1%
Annual Yield % from dividends1.473.2745%
Returns for 1 year5.8911.4451%
Returns for 3 years-30.89-10.67289%
Returns for 5 years-9.8116.99-58%
Returns for 10 years-6.9412.90-54%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ATS25.550.42
+1.67%
ATS Corp
VRSN183.56-1.33
-0.72%
VeriSign
AMTB20.98-0.24
-1.13%
Amerant Bancorp
TLYS4.75-0.19
-3.85%
Tilly's
MIRA1.58-0.12
-7.06%
MIRA Pharmaceuticals